ALTRAPHARMA Invest ApS: Financial statements 2019
CVR: 34483884
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 158,006 and a net result of DKK 109,552. Equity in the 2019 report amounted to DKK 292,318. The solvency ratio was 64.7%.
- Gross Profit
- DKK 158,006
- Profit/Loss
- DKK 109,552
- Equity
- DKK 292,318
- Total Assets
- DKK 451,573
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 158 t. | 110 t. | 292 t. | 0 |
| 2017 | - | 473 t. | 270 t. | 517 t. | 0 |
| 2016 | - | 1.2 mio. | 67 t. | 247 t. | 0 |
| 2015 | - | 843 t. | 7 t. | 379 t. | - |
| 2014 | - | 1.4 mio. | 223 t. | 623 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.